A new healthcare solution is available for Louisiana residents who recently lost health insurance and are currently uninsured due to COVID-19.
A new healthcare solution is available for Louisiana residents who recently lost health insurance and are currently uninsured due to coronavirus disease 2019. The new Ochsner Health Care Bridge program is a 3-month program designed to keep individuals connected to their Ochsner physicians and the health care services they need to manage chronic conditions, get prescriptions filled, and in many cases, get prescription drug assistance.
“Ochsner Health recognizes that consistent access to ongoing care is key to helping individuals live healthier lives and our virtual platform enables them to stay connected in ways that are also safe and convenient. At a time when many of our community members have lost their jobs and health insurance, this program is geared to provide a bridge to help individuals maintain relationships with their providers and get the high quality healthcare they need,” said Robert Hart, MD, executive vice president and chief medical officer at Ochsner Health.
Over a 3-month period, Ochsner Health Care Bridge enrollees can participate in two virtual visits with their Ochsner primary care provider and securely communicate with their care team, obtain test results and manage medication requests via the online MyOchsner patient portal. Individuals who are not currently established with an Ochsner primary care provider will be connected with one.
Learn more.
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More